First Republic Investment Management, Inc. Haemonetics Corp Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$51.81 - $118.56 $127,867 - $292,606	-2,468 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $220,132 - $276,588	-1,983 Reduced 44.55%	2,468 $274,000
Q4 2020 Feb 16, 2021	BUY	$88.75 - $119.95 $135,965 - $183,763	1,532 Added 52.48%	4,451 $529,000
Q3 2020 Nov 12, 2020	BUY	$75.65 - $93.58 $220,822 - $273,160	2,919 New	2,919 $255,000

Others Institutions Holding HAE

# of Institutions

334

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$532 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$461 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$396 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$375 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$359 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account